GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eris Lifesciences ERIS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,261.60

+2.23%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹31.29bn

FY2017FY2026

Net income

₹6.20bn

FY2017FY2026

Free cash flow

₹500.7m

FY2017FY2026

Shareholders' equity

₹39.03bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹31.29bn₹28.79bn₹19.91bn₹16.62bn₹13.26bn₹11.93bn₹10.58bn₹9.67bn₹8.27bn₹7.49bn
Research and development₹43.3m₹24.4m₹57.2m₹61.0m₹327.4m₹50.9m₹42.0m₹41.1m₹7.7m—
Operating income₹8.41bn₹7.03bn₹4.95bn₹4.22bn₹4.46bn₹3.96bn₹3.34bn₹3.40bn₹3.23bn₹2.47bn
Net income₹6.20bn₹3.52bn₹3.92bn₹3.82bn₹4.06bn₹3.55bn₹2.96bn₹2.91bn₹2.94bn₹2.47bn
Diluted earnings per share45.3225.8328.7828.0529.8626.1221.8121.1221.4017.96

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹73.66bn₹70.33bn₹70.49bn₹36.67bn₹22.72bn₹18.35bn₹15.52bn₹15.54bn₹14.60bn₹6.41bn
Cash and short-term investments₹673.0m₹2.28bn₹13.39bn₹892.4m₹2.12bn₹1.31bn₹1.42bn₹3.22bn₹1.04bn₹2.61bn
Total liabilities₹34.70bn₹37.61bn₹38.27bn₹14.47bn₹3.64bn₹2.58bn₹2.56bn₹3.85bn₹5.74bn₹1.01bn
Debt₹23.59bn₹24.78bn₹27.81bn₹8.77bn₹844.1m₹67.8m₹121.4m₹1.76bn₹3.77bn₹77.6m
Shareholders' equity₹39.03bn₹28.54bn₹25.86bn₹21.96bn₹19.08bn₹15.76bn₹12.96bn₹11.51bn₹8.61bn₹5.40bn
Shares outstanding137m136m136m136m136m136m136m138m137m137m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹3.47bn₹10.65bn₹4.86bn₹2.92bn₹3.78bn₹3.75bn₹2.71bn₹2.23bn₹2.35bn₹2.00bn
Capital spending−₹2.97bn−₹1.55bn−₹1.29bn−₹8.41bn−₹1.21bn−₹257.6m−₹1.51bn−₹380.0m−₹251.0m−₹497.5m
Free cash flow₹500.7m₹9.10bn₹3.57bn−₹5.50bn₹2.57bn₹3.50bn₹1.20bn₹1.85bn₹2.10bn₹1.50bn
Dividends paid—−₹1.00bn—−₹999.1m−₹816.2m−₹746.8m−₹469.8m−₹469.8m−₹389.7m−₹169.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹8.69bn₹7.67bn₹8.01bn₹7.90bn₹7.72bn₹7.03bn₹7.22bn₹7.39bn
Operating income₹2.24bn₹2.04bn₹2.11bn₹2.19bn₹2.06bn₹1.76bn₹1.69bn₹1.84bn
Net income₹1.42bn₹2.82bn₹997.2m₹1.20bn₹1.18bn₹934.5m₹836.3m₹916.5m
Diluted earnings per share10.4220.607.328.828.666.866.146.73
Cash from operations———₹2.39bn—₹10.67bn—₹4.85bn
Capital spending———−₹1.17bn—−₹1.55bn—−₹573.0m
Free cash flow———₹1.22bn—₹9.12bn—₹4.28bn
Total assets—₹73.66bn—₹71.60bn—₹70.33bn—₹70.22bn
Cash and short-term investments—₹673.0m₹747.5m₹839.2m₹2.05bn₹2.28bn₹2.43bn₹2.43bn
Debt—₹23.27bn—₹23.89bn—₹24.78bn—₹27.35bn
Shareholders' equity—₹39.03bn₹35.03bn₹30.91bn₹32.72bn₹28.54bn₹31.77bn₹27.71bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.5%21.3%18.0%
Operating income25.8%16.2%18.5%
Net income17.5%11.8%16.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.7%25.5%27.1%28.7%
Net margin16.2%18.1%20.6%23.0%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings27.158.647.932.521.729.226.622.432.045.3
Price to sales5.37.29.47.56.68.77.56.711.414.9

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 13 Feb 2025.

FY2025FY2023FY2022FY2021FY2020
Paid in the year7.357.356.015.502.87

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.